Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity
Toby A. Eyre(Churchill Hospital), Chris S.R Hatton(Churchill Hospital), Andrew McMillan(Nottingham University Hospitals NHS Trust), Mark Bishton(Peter MacCallum Cancer Centre), Arief Gunawan(St Thomas' Hospital), Nicolás Martínez‐Calle(Nottingham University Hospitals NHS Trust), Stephen Booth(Royal Berkshire Hospital), Catherine Hildyard(Milton Keynes Hospital), Hannah Plaschkes(University of Oxford), Christopher P. Fox(Nottingham University Hospitals NHS Trust), Graham P. Collins(Churchill Hospital), Paul Fields(St Thomas' Hospital), Rebecca Oliver(University Hospitals Bristol NHS Foundation Trust), John Griffith(Great Western Hospital), Carolyn Mercer(University of Oxford), Julia Wolf(Great Western Hospital), Amy A. Kirkwood(Cancer Research UK)
Cited by 65
Related Papers
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
|Blood|2006|843
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
|Journal of Hepatology|2020|525